Ovarian Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cancer, including details on symptoms, causes, treatment, information.

Volume 5 (2008), Issue 4 (April)

1. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma.
   Cancer Sci, 99(4): 653-8. [Abstract] [Full-text]
2. Phase I trial of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreduction for advanced intra-abdominal malignancy.
   Ann Surg Oncol, 15(5): 1407-13. [Abstract] [Full-text]
3. Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.
   Cancer Res, 68(7): 2498-506. [Abstract] [Full-text]
4. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
   Cancer Res, 68(7): 2329-39. [Abstract] [Full-text]
5. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
   Cancer Res, 68(7): 2166-75. [Abstract] [Full-text]
6. Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy.
   Pediatr Blood Cancer, 50(5): 1060-2. [Abstract] [Full-text]
7. Transient ectopic expression as a method to detect genes conferring drug resistance.
   Int J Cancer, 122(11): 2641-5. [Abstract] [Full-text]
8. Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma.
   Oncogene, 27(15): 2137-47. [Abstract] [Full-text]
9. A qualitative study examining psychosocial distress, coping, and social support across the stages and phases of epithelial ovarian cancer.
   Health Care Women Int, 29(4): 366-83. [Abstract] [Full-text]
10. Amplification of 11q13 in ovarian carcinoma.
    Genes Chromosomes Cancer, 47(6): 481-9. [Abstract] [Full-text]
11. Successful treatment for advanced small cell carcinoma of the ovary.
    Pediatr Blood Cancer, 50(6): 1276-7. [Abstract] [Full-text]
12. Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
    Cancer, 112(8): 1733-43. [Abstract] [Full-text]
13. Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy.
    Cancer, 112(8): 1726-32. [Abstract] [Full-text]
14. Participation of OCT3/4 and beta-catenin during dysgenetic gonadal malignant transformation.
    Cancer Lett, 263(2): 204-11. [Abstract] [Full-text]
15. Unusual presentation of acute ovarian torsion in an adolescent.
    Am J Emerg Med, 26(4): 520.e1-3. [Abstract] [Full-text]
16. Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.
    Oncogene, 27(19): 2737-45. [Abstract] [Full-text]
17. Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women.
    Am J Epidemiol, 167(9): 1059-69. [Abstract] [Full-text]
18. Ependymomas of the central nervous system and adult extra-axial ependymomas are morphologically and immunohistochemically distinct--a comparative study with assessment of ovarian carcinomas for expression of glial fibrillary acidic protein.
    Am J Surg Pathol, 32(5): 710-8. [Abstract] [Full-text]
19. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    Am J Surg Pathol, 32(5): 645-55. [Abstract] [Full-text]
20. An immunohistochemical and morphological analysis of post-chemotherapy ovarian carcinoma.
    J Clin Pathol, 61(5): 652-7. [Abstract] [Full-text]
21. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas.
    Nat Genet, 40(5): 650-5. [Abstract] [Full-text]
22. Haematological evaluation of weekly therapy with topotecan for the treatment of recurrent ovarian cancer resistant to platinum-based therapy.
    Oncology, 73(3): 177-84. [Abstract] [Full-text]

© 2004-2008 Ovarian Cancer Research Today. All Rights Reserved.